Philippe Armand

Philippe Armand is Professor of Medicine at Harvard Medical School and Chief of the Lymphoma Division at Dana-Farber Cancer Institute. His clinical expertise includes CAR T-cell therapy, stem cell transplantation, and novel lymphoma treatments.

Research focuses on developing immunotherapies for hematologic malignancies, particularly CAR T-cell applications and transplantation protocols. As Harold and Virginia Lash Endowed Chair, he leads clinical trials investigating innovative approaches for Hodgkin and non-Hodgkin lymphoma.

Medical training includes residency at Brigham and Women's Hospital and hematology/oncology fellowship at Dana-Farber/Partners CancerCare. Board-certified in hematology, oncology, and internal medicine.

Clinical interests encompass both adult and pediatric lymphoma cases, with specialized programs for CNS lymphoma and chronic lymphocytic leukemia.